ORIC
Common StockOric Pharmaceuticals, Inc.
Reported Shares
4.6M
Position Mix
No options reported
Reported Value
$62.4M
Portfolio Weight
57.39%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$108.7M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
ORIC
Common StockOric Pharmaceuticals, Inc.
Reported Shares
4.6M
Position Mix
No options reported
Reported Value
$62.4M
Portfolio Weight
57.39%
LEGN
Depositary ReceiptLegend Biotech Corp
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$23.5M
Portfolio Weight
21.64%
RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
83.1K
Position Mix
No options reported
Reported Value
$17.1M
Portfolio Weight
15.70%
NBP
Depositary ReceiptNovaBridge Biosciences
Reported Shares
2.9M
Position Mix
No options reported
Reported Value
$3.9M
Portfolio Weight
3.61%
KURA
Common StockKura Oncology, Inc.
Reported Shares
139.7K
Position Mix
No options reported
Reported Value
$1.5M
Portfolio Weight
1.38%
KRRO
Common StockKorro Bio, Inc.
Reported Shares
30.3K
Position Mix
No options reported
Reported Value
$299.9K
Portfolio Weight
0.28%